+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Anticholinergic Drugs - Global Market Trajectory & Analytics

  • PDF Icon

    Report

  • April 2021
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 5302222
Global Anticholinergic Drugs Market to Reach $7.8 Billion by 2027

Amid the COVID-19 crisis, the global market for Anticholinergic Drugs estimated at US$5.8 Billion in the year 2020, is projected to reach a revised size of US$7.8 Billion by 2027, growing at a CAGR of 4.4% over the analysis period 2020-2027. Synthetic Compounds, one of the segments analyzed in the report, is projected to record a 4.6% CAGR and reach US$5.1 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Natural segment is readjusted to a revised 4% CAGR for the next 7-year period.





The U.S. Market is Estimated at $1.6 Billion, While China is Forecast to Grow at 7.1% CAGR

The Anticholinergic Drugs market in the U.S. is estimated at US$1.6 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.6 Billion by the year 2027 trailing a CAGR of 7.1% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.5% and 3.5% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3.2% CAGR.

Semi-Synthetic Compounds Segment to Record 3.9% CAGR

In the global Semi-Synthetic Compounds segment, USA, Canada, Japan, China and Europe will drive the 3.6% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$474.7 Million in the year 2020 will reach a projected size of US$610.1 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$1 Billion by the year 2027, while Latin America will expand at a 4.2% CAGR through the analysis period.

Select Competitors (Total 40 Featured):
  • Allergan Plc
  • Astellas Pharma Inc.
  • Boehringer Ingelheim International GmbH
  • GlaxoSmithKline Plc
  • Johnson & Johnson Services Inc.
  • Mylan N.V.
  • Novartis AG
  • Pfizer Inc.
  • Sanofi
  • Teva Pharmaceutical Industries Ltd
Frequently Asked Questions about the Global Market for Anticholinergic Drugs

What is the estimated value of the Global Market for Anticholinergic Drugs?

The Global Market for Anticholinergic Drugs was estimated to be valued at $5.8 Billion in 2020.

What is the growth rate of the Global Market for Anticholinergic Drugs?

The growth rate of the Global Market for Anticholinergic Drugs is 4.3%, with an estimated value of $7.8 Billion by 2027.

What is the forecasted size of the Global Market for Anticholinergic Drugs?

The Global Market for Anticholinergic Drugs is estimated to be worth $7.8 Billion by 2027.

Who are the key companies in the Global Market for Anticholinergic Drugs?

Key companies in the Global Market for Anticholinergic Drugs include Allergan Plc, Astellas Pharma Inc., Boehringer Ingelheim International GmbH, GlaxoSmithKline Plc, Johnson & Johnson Services Inc., Mylan N.V., Novartis AG, Pfizer Inc. and Teva Pharmaceutical Industries Ltd.

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERS4. GLOBAL MARKET PERSPECTIVE
III. MARKET ANALYSIS
  • UNITED STATES
  • CANADA
  • JAPAN
  • CHINA
  • EUROPE
  • FRANCE
  • GERMANY
  • ITALY
  • UNITED KINGDOM
  • SPAIN
  • RUSSIA
  • REST OF EUROPE
  • ASIA-PACIFIC
  • AUSTRALIA
  • INDIA
  • SOUTH KOREA
  • REST OF ASIA-PACIFIC
  • LATIN AMERICA
  • ARGENTINA
  • BRAZIL
  • MEXICO
  • REST OF LATIN AMERICA
  • MIDDLE EAST
  • IRAN
  • ISRAEL
  • SAUDI ARABIA
  • UNITED ARAB EMIRATES
  • REST OF MIDDLE EAST
  • AFRICA

IV. COMPETITION
  • Total Companies Profiled: 40

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Allergan Plc
  • Astellas Pharma Inc.
  • Boehringer Ingelheim International GmbH
  • GlaxoSmithKline Plc
  • Johnson & Johnson Services Inc.
  • Mylan N.V.
  • Novartis AG
  • Pfizer Inc.
  • Sanofi
  • Teva Pharmaceutical Industries Ltd